DE602004026830D1 - Verwendung von pvp-iod liposomen zur behandlung von atopischer dermatitis - Google Patents

Verwendung von pvp-iod liposomen zur behandlung von atopischer dermatitis

Info

Publication number
DE602004026830D1
DE602004026830D1 DE602004026830T DE602004026830T DE602004026830D1 DE 602004026830 D1 DE602004026830 D1 DE 602004026830D1 DE 602004026830 T DE602004026830 T DE 602004026830T DE 602004026830 T DE602004026830 T DE 602004026830T DE 602004026830 D1 DE602004026830 D1 DE 602004026830D1
Authority
DE
Germany
Prior art keywords
iod
pvp
liposomes
treatment
atopic dermatitis
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE602004026830T
Other languages
English (en)
Inventor
Karen Reimer
Wolfgang Fleischer
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Euro Celtique SA
Original Assignee
Euro Celtique SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Euro Celtique SA filed Critical Euro Celtique SA
Publication of DE602004026830D1 publication Critical patent/DE602004026830D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/18—Iodine; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/785—Polymers containing nitrogen
    • A61K31/787—Polymers containing nitrogen containing heterocyclic rings having nitrogen as a ring hetero atom
    • A61K31/79—Polymers of vinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/28—Mercury; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/38—Silver; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/02—Local antiseptics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Dispersion Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE602004026830T 2003-02-24 2004-02-12 Verwendung von pvp-iod liposomen zur behandlung von atopischer dermatitis Expired - Lifetime DE602004026830D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP03003283A EP1449521A1 (de) 2003-02-24 2003-02-24 Verwendung von PVP-Jod zur Behandlung von atopischer Dermatitis
PCT/EP2004/001317 WO2004073683A1 (en) 2003-02-24 2004-02-12 Use of pvp-iodine liposomes for treatment of atopic dermatitis

Publications (1)

Publication Number Publication Date
DE602004026830D1 true DE602004026830D1 (de) 2010-06-10

Family

ID=32731524

Family Applications (1)

Application Number Title Priority Date Filing Date
DE602004026830T Expired - Lifetime DE602004026830D1 (de) 2003-02-24 2004-02-12 Verwendung von pvp-iod liposomen zur behandlung von atopischer dermatitis

Country Status (8)

Country Link
EP (2) EP1449521A1 (de)
AR (1) AR043247A1 (de)
AT (1) ATE465716T1 (de)
DE (1) DE602004026830D1 (de)
ES (1) ES2345104T3 (de)
TW (1) TW200503778A (de)
UY (1) UY28198A1 (de)
WO (1) WO2004073683A1 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2415362T3 (es) 2005-04-08 2013-07-25 Mie University Agente externo para tratar heridas
CN102335142B (zh) * 2011-10-25 2014-03-26 上海理工大学 一种能够原位自组装成难溶药物的纳米脂质体的复合微球及其制备方法
CA2990627A1 (en) 2015-06-22 2016-12-29 Infection Containment Company, LLC Topical antiseptic system
US11273175B2 (en) * 2017-06-26 2022-03-15 Next Science IP Holdings Pty Ltd Method for treating fibrillar collagenous conditions
CN112206322A (zh) * 2020-11-13 2021-01-12 深圳先进技术研究院 杀菌剂及其制备方法和应用

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1180017B8 (de) * 1999-05-27 2010-05-19 Euro-Celtique S.A. Formulierungen mit povidon-iod zur behandlung von wunden

Also Published As

Publication number Publication date
EP1596826A1 (de) 2005-11-23
EP1596826B1 (de) 2010-04-28
UY28198A1 (es) 2004-08-31
AR043247A1 (es) 2005-07-20
ATE465716T1 (de) 2010-05-15
ES2345104T3 (es) 2010-09-15
TW200503778A (en) 2005-02-01
WO2004073683A1 (en) 2004-09-02
EP1449521A1 (de) 2004-08-25

Similar Documents

Publication Publication Date Title
DE60325770D1 (de) Verwendung von rimexolon zur behandlung von augentrockenheit
ATE518841T1 (de) Herstellung und verwendung von arylalkylsäurederivaten zur behandlung von obesitas
DE602005007717D1 (de) Imidazolverbindungen zur behandlung von neurodegenerativen erkrankungen
DE602004022061D1 (de) Verwendung von modifizierten cyclosporinen zur behandlung von hcv-erkrankungen
ATE524479T1 (de) Sulfonamidthiazolpyridinderivate als zur behandlung von typ-2-diabetes geeignete glucokinaseaktivatoren
DE602005005810D1 (de) Verwendung von substituierten chinolin-derivaten zur behandlung von arzneimittelresistenten mycobakteriellen erkrankungen
ATE410430T1 (de) 2,3-dihydro-6-nitroimidazoä2,1- büoxazolverbindungen zur behandlung von tuberkulose
DE60328517D1 (de) Neue verwendung von lycopin zur behandlung von erkrankungen im zusammenhang mit androgenwirkung
ATE369133T1 (de) Zur behandlung von schmerzen geeignete therapeutische mittel
DE502004010131D1 (de) Pyridopyrimidinone zur behandlung von krebserkrankungen
DE602006017367D1 (de) Amino-oxo-indolyliden-verbindungen zur verwendung in der behandlung von juckender kopfhaut
DE602006007323D1 (de) VERWENDUNG VON BAFF ZUR BEHANDLUNG Th2-INDUZIERTER LEIDEN
DE602005016141D1 (de) S-mirtazapin zur behandlung von hitzewallungen
DE602006003094D1 (de) 4-phenyl-5-oxo-1,4,5,6,7,8-hexahydrochinolin-derivate zur behandlung von unfruchtbarkeit
ATE504297T1 (de) Visnadin zur behandlung von kopfhautjucken
DE602004022153D1 (de) Verbindungen zur behandlung von obesitas
DE602004022035D1 (de) Verwendung von pthalide derivativen zur behandlung
ATE423099T1 (de) Zur behandlung von schmerzen geeignete piperazine
ATE482707T1 (de) 1-ä2h-1-benzopyran-2-on-8-ylü- piperazin- derivate zur behandlung von schmerzen
DE602005015434D1 (de) Mittel zur behandlung von psychoneurotischen krankheiten
DE60117122D1 (de) Verwendung von mirtazapin zur behandlung von schlafstörungen
DE602004026830D1 (de) Verwendung von pvp-iod liposomen zur behandlung von atopischer dermatitis
ATE446757T1 (de) 1-ä2h-1-benzopyran-2-one-8-ylü- piperazinderivative zur behandlung von bewegungsstörungen
DE602004026067D1 (de) Gerät zur Behandlung von Füßen
DE50308460D1 (de) Verwendung von ambroxol zur behandlung von chronischen schmerzen

Legal Events

Date Code Title Description
8364 No opposition during term of opposition